Choice of Abstracts & Summary of the presentation from Thomas Seufferlein: Improving the outcome of patients with metastatic pancreatic cancer

Sunil Hingorani, et al.

O-003 PEGPH20 improves pfs in patients with metastatic pancreatic ductal adenocarcinoma: A randomized phase 2 study in combination with nab-paclitaxel/gemcitabine (password restricted access)

Andrew Hendifar, et al.

O-028 Tumor Hyaluronan May Predict Benefit From PEGPH20 When Added to nab Paclitaxel/Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (mPDA) (password restricted access)

Thomas Seufferlein, MD

Improving the outcome of patients with metastatic pancreatic cancer (password restricted access)

Written summary of Thomas Seufferlein's presentation :

Summary